What's your price prediction/target Merchant??
I personally expect to see a bit of a pullback following the annual report being released as people will sell the headline even though all the information is already known to the market from the 4C reports issued through FY '24.
From there I'd expect to see a slow and steady build through to the end of the calendar year to at least 1.5c as the Limepay deal settles and any new deals they've got in the wings come online. After all, they're currently doing $2.8m in gross revenue and the first revenue milestone requires them to get to $4.2m annualised gross revenue within 12 months, so I'd expect they have something(s) that were pending deals waiting to be be monetised in order to hit the first target.
That's just my view as I certainly wouldn't want to commit to receiving over 50% of the sale proceeds upon hitting performance based revenue targets if I didn't think I'd get there in the required time.
- Forums
- ASX - By Stock
- SPX
- Bottom is in. Get ready for SPENDA to bounce!
SPX
spenda limited
Add to My Watchlist
9.09%
!
0.6¢

Bottom is in. Get ready for SPENDA to bounce!, page-1433
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.001(9.09%) |
Mkt cap ! $27.69M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $23.32K | 3.880M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 18216262 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.006 |
48 | 22729523 | 0.005 |
8 | 15700000 | 0.004 |
9 | 26100000 | 0.003 |
5 | 17000002 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 17544441 | 26 |
0.008 | 3921694 | 23 |
0.009 | 9234397 | 15 |
0.010 | 842781 | 5 |
0.011 | 527004 | 4 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online